August 24, 2005 Nationwide Insomnia Study Takes Place at Regions Study Participants Sought from Twin Cities and Surrounding Area St. Paul, Minn. Regions Hospital has been selected as one of several hospitals in the United States to participate in a study to evaluate the effectiveness of medication to treat primary insomnia in adults ages 18 to 64. Insomnia is characterized by at least one month of difficulty falling or staying asleep. This frequently causes distress in the individuals daytime functioning and ability to feel rested. Good candidates for this study include those who have trouble falling asleep most nights of the week and have trouble staying asleep during the night. However, the individual need not have an official diagnosis of primary insomnia. "Insomnia can be a very debilitating illness," says Elizabeth Reeve, M.D., psychiatrist at Regions. "A lack of quality sleep can have a negative impact on everything from motor skills to our ability to communicate effectively. Individuals who seek treatment have the opportunity to drastically increase their quality of life." The research study at Regions will provide qualified volunteer participants with health assessments, lab tests and study medications at no cost. The volunteer will be asked to take the study medication once a day and attend periodic hospital visits. As in most studies, some volunteers will be given a placebo to more accurately trace the medication's effectiveness. Regions Hospital is a Level I Trauma Center and teaching hospital serving Minnesota and western Wisconsin for more than 130 years. Regions is a premier, full-service, private hospital providing outstanding medical and surgical care with special programs in heart, women's care, cancer, orthopedics, neurology, burn and emergency care. The hospital is part of the HealthPartners family of health care organizations. Additional information is available at www.regionshospital.com.
|
||||||||||
|